4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-155526
Chief Executive Officer gave up 300,444 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-12-13 | Shares withheld for taxes : show line 1 in the form | −300,444 | $1.27 | $381,564 | 816,789 | D |
Loading xslF345X03/doc4.xml…